Is the DEA actually fighting FOR cannabis rescheduling? 🤯

For 50 years, the cannabis industry has viewed the DEA as the ultimate gatekeeper of prohibition. But Day 1 of the historic DEA rescheduling hearings told a completely different story. High Spirits host AnnaRae Grabstein sat down with Laura Fogelman (Chief of Staff & Head of Strategic Communications at PAX), who was one of only 25 observers allowed inside the heavily secured, non-livestreamed room at DEA Headquarters. Her biggest takeaway? The vibe is shifting. 🔍 Key Insights From Inside the Room: The Government Came Out Swinging: The DEA’s legal team and the FDA vigorously defended the move to Schedule III, laying out a precise, methodical, and scientific case. Beyond the Bare Minimum: While only one currently accepted medical use is required to move cannabis off Schedule I, the FDA’s review robustly proved substantive evidence for three qualifying conditions: anorexia, nausea/vomiting, and pain. Prohibition Theater? Think Again: The DEA’s counsel was practically on her feet the entire afternoon, repeatedly objecting to out-of-scope, emotional arguments brought by opposition groups. The Verdict: "I definitely left with a lot more optimism than I arrived with," says Laura. This isn't just a formality—the government is actively defending reform. 👉 What are your thoughts on this historic shift? Are you feeling more optimistic about a Schedule III future? Let’s discuss in the comments. #CannabisReform #DEAHearings #CannabisBusiness #PolicyChange #HighSpiritsPodcast #ScheduleIII